Research ExplorerPublicationsThe putative oncogene CPI-17 is up-regulated in schwannoma

The putative oncogene CPI-17 is up-regulated in schwannoma

Standard

The putative oncogene CPI-17 is up-regulated in schwannoma. / Hagel, Christian; Dornblut, Carsten; Schulz, Alexander; Wiehl, Ulrike; Friedrich, Reinhard E; Huckhagel, Torge; Mautner, Victor-Felix; Morrison, Helen.

In: NEUROPATH APPL NEURO, Vol. 42, No. 7, 12.2016, p. 664-668.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Hagel, C, Dornblut, C, Schulz, A, Wiehl, U, Friedrich, RE, Huckhagel, T, Mautner, V-F & Morrison, H 2016, 'The putative oncogene CPI-17 is up-regulated in schwannoma', NEUROPATH APPL NEURO, vol. 42, no. 7, pp. 664-668. https://doi.org/10.1111/nan.12330

APA

Hagel, C., Dornblut, C., Schulz, A., Wiehl, U., Friedrich, R. E., Huckhagel, T., Mautner, V-F., & Morrison, H. (2016). The putative oncogene CPI-17 is up-regulated in schwannoma. NEUROPATH APPL NEURO, 42(7), 664-668. https://doi.org/10.1111/nan.12330

Vancouver

Hagel C, Dornblut C, Schulz A, Wiehl U, Friedrich RE, Huckhagel T et al. The putative oncogene CPI-17 is up-regulated in schwannoma. NEUROPATH APPL NEURO. 2016 Dec;42(7):664-668. https://doi.org/10.1111/nan.12330

Bibtex

@article{2986529e93554750b8a5df0a17951bdc,
title = "The putative oncogene CPI-17 is up-regulated in schwannoma",
abstract = "CPI-17 (PPP1R14A protein phosphatase 1 regulatory inhibitor subunit 14A, 17 kDa) was previously described to act as an oncoprotein in the merlin pathway. The myosin phosphatase and its substrate merlin are part of a tumour suppressor cascade that can be blocked in two ways; by mutation of the NF2 gene encoding the tumour suppressor protein merlin and by up-regulation of the specific myosin phosphatase inhibitor, CPI-17. This article is protected by copyright. All rights reserved.",
author = "Christian Hagel and Carsten Dornblut and Alexander Schulz and Ulrike Wiehl and Friedrich, {Reinhard E} and Torge Huckhagel and Victor-Felix Mautner and Helen Morrison",
note = "Document Type:Letter",
year = "2016",
month = dec,
doi = "10.1111/nan.12330",
language = "English",
volume = "42",
pages = "664--668",
journal = "NEUROPATH APPL NEURO",
issn = "0305-1846",
publisher = "Wiley-Blackwell",
number = "7",

}

RIS

TY - JOUR

T1 - The putative oncogene CPI-17 is up-regulated in schwannoma

AU - Hagel, Christian

AU - Dornblut, Carsten

AU - Schulz, Alexander

AU - Wiehl, Ulrike

AU - Friedrich, Reinhard E

AU - Huckhagel, Torge

AU - Mautner, Victor-Felix

AU - Morrison, Helen

N1 - Document Type:Letter

PY - 2016/12

Y1 - 2016/12

N2 - CPI-17 (PPP1R14A protein phosphatase 1 regulatory inhibitor subunit 14A, 17 kDa) was previously described to act as an oncoprotein in the merlin pathway. The myosin phosphatase and its substrate merlin are part of a tumour suppressor cascade that can be blocked in two ways; by mutation of the NF2 gene encoding the tumour suppressor protein merlin and by up-regulation of the specific myosin phosphatase inhibitor, CPI-17. This article is protected by copyright. All rights reserved.

AB - CPI-17 (PPP1R14A protein phosphatase 1 regulatory inhibitor subunit 14A, 17 kDa) was previously described to act as an oncoprotein in the merlin pathway. The myosin phosphatase and its substrate merlin are part of a tumour suppressor cascade that can be blocked in two ways; by mutation of the NF2 gene encoding the tumour suppressor protein merlin and by up-regulation of the specific myosin phosphatase inhibitor, CPI-17. This article is protected by copyright. All rights reserved.

U2 - 10.1111/nan.12330

DO - 10.1111/nan.12330

M3 - SCORING: Journal article

C2 - 27248983

VL - 42

SP - 664

EP - 668

JO - NEUROPATH APPL NEURO

JF - NEUROPATH APPL NEURO

SN - 0305-1846

IS - 7

ER -